Majority of U.S. level III & IV NICUs in 2025 used Prolacta’s 100% breastmilk-based fortifiers & formulas to improve outcomes for premature infants
Type: Press Releases
Topic(s): Company
Most comprehensive meta-analysis to date finds an exclusive human milk diet is associated with up to 49% lower risk of necrotizing enterocolitis in premature infants
Type: Press Releases
Topic(s): Company Product
Prolacta Bioscience approaches 20 years nourishing extremely premature babies as #1 hospital provider of human milk-based fortifiers and formulas
Type: Press Releases
Topic(s): Company Product
NICU Awareness Month milestone: 125,000 preemies helped by Prolacta Bioscience’s 100% breast milk-based nutrition
Type: Press Releases
Topic(s): Company
Study: Despite being born earlier and weighing less, preemies fed Prolacta’s Exclusive Human Milk Diet had lower motor skill disability risk by age 3 compared to larger preemies fed cow milk-based products
Type: Press Releases
Topic(s): Clinical Studies Long-Term outcomes
Good news for parents during Gastroschisis Awareness Month: Surgifort nutritional fortifier supports healing and growth for babies post-surgery
Type: Press Releases
Topic(s): Congenital Gastrointestinal Disorders Gastroschisis Product
Improved survival and growth while cutting malnutrition for premature infants fed human milk-based fortifiers at Sydney hospital
Type: Press Releases
Topic(s): Clinical Studies Company
Prolacta Bioscience neonatologist Dr. Erin Hamilton Spence earns breastfeeding and lactation medicine certification held by fewer than 100 North American physicians
Type: Employee Stories Press Releases
Topic(s): Company
FDA approves first human milk-based fortifier for term infants to support growth and recovery following surgery for Gastroschisis
Type: Press Releases
Topic(s): Feeding Intolerance Growth Product
Not finding the reference you’re looking for?
Use our main search field or email us at info@prolacta.com